Arcturus Therapeutics Holdings Inc share price logo

Arcturus Therapeutics Holdings Inc Share Price

NASDAQ: ARCT

Small Cap

$6.91

+0.15

(+2.22%)

Live

as on

Arcturus Therapeutics Holdings Inc Stock Performance

as on March 31, 2026 at 1:08 am IST

  • Day's Low

    Day's High

    $6.92
    $7.16
    downward going graph

    -0.14%

    Downside

    3.62%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $5.85
    $24.17
    downward going graph

    15.34%

    Downside

    249.78%

    Upside

    downward going graph

Arcturus Therapeutics Holdings Inc share price movements today

Previous Close
$6.76
Open
$6.99
Volume
112.6K
Day's Low - High
$6.92 - $7.16
52 Week Low - High
$5.85 - $24.17

Arcturus Therapeutics Holdings Inc Historical Returns

1 Month Return
-19.04 %
3 Month Return
+ 9.21 %
1 Year Return
-41.62 %
3 Year Return
-67.25 %
5 Year Return
-82.55 %

Arcturus Therapeutics Holdings Inc Stock Fundamentals & Key Indicators

Check Arcturus Therapeutics Holdings Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$192.1M

EPS (TTM)

-4.0254

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-7.83

Industry PE ratio

-4.138122977346279

PEG Ratio

0

EBITDA

-73.2M

Revenue (TTM)

82.0M

Profit Margin

-80.19%

Return On Equity TTM

-28.92%

Arcturus Therapeutics Holdings Inc Stock Valuation

Track how Arcturus Therapeutics Holdings Inc P/E has moved over time to understand its valuation trends.

Arcturus Therapeutics Holdings Inc in the last 5 years

  • Overview

  • Trends

Lowest (-22.85x)

December 31, 2023

Today (-7.83x)

March 30, 2026

Industry (-4.14x)

March 30, 2026

Highest (51.28x)

December 31, 2022

LowHigh

Today’s Price to Earnings Ratio: -7.83x

Arcturus Therapeutics Holdings Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Arcturus Therapeutics Holdings Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Arcturus Therapeutics Holdings Inc image
Arcturus Therapeutics Holdings Inc
BUY$192.1M-82.55%-7.83-80.19%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$42.1B134.86%136.798.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$110.0B103.33%28.2532.94%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$32.5BNA115.055.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$78.0B56.74%17.7931.41%

Stock Returns calculator for Arcturus Therapeutics Holdings Inc Stock including INR - Dollar returns

The Arcturus Therapeutics Holdings Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Arcturus Therapeutics Holdings Inc investment value today

Current value as on today

₹66,125

Returns

-₹33,875

(-33.87%)

Returns from Arcturus Therapeutics Holdings Inc Stock

-₹40,328 (-40.33%)

Dollar Impact

₹6,453 (+6.45%)

Analyst Recommendation on Arcturus Therapeutics Holdings Inc Stock

Based on 16 analysts

BUY

87.50%

Buy

6.25%

Hold

6.25%

Sell

Based on 16 analysts, 87.5% of analysts recommend a 'BUY' rating for Arcturus Therapeutics Holdings Inc. Average target price of $23.3

Arcturus Therapeutics Holdings Inc Share Price Target

Get share price movements and forecasts by analysts on Arcturus Therapeutics Holdings Inc.

What analysts predicted

70.34%UPSIDE

Target Price

$23.3

Current Price

$6.91

Analyzed by

16 Analysts

Target

$23.30

Arcturus Therapeutics Holdings Inc target price $23.3, a slight upside of 70.34% compared to current price of $6.91. According to 16 analysts rating.

Arcturus Therapeutics Holdings Inc Stock’s Investor Sentiment and Interest

Search interest for Arcturus Therapeutics Holdings Inc Stock has decreased by -52% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-52% versus previous 30 day period

Arcturus Therapeutics Holdings Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
43
25
32
45
38
21
29
24
17
3
Gross Profit
43
25
32
45
38
21
29
24
13
2
Operating Income
-19
-18
-30
-21
-10
-33
-16
-11
-16
-30
EBITDA
-18
-10
-29
-20
-6
-29
-16
-10
-12
-32
Interest Expense
0
0
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-15
-11
-26
-17
-7
-30
-14
-9
-13
-29
Income Tax Expense
0
0
0
0
0
0
-16
0
-16
0
Net Income
-16
-11
-26
-17
-6
-30
-14
-9
-13
-29
Net Profit Margin
-37.40%
-46.68%
-82.27%
-37.45%
-17.78%
-142.88%
-47.91%
-37.45%
-78.41%
-943.82%

Arcturus Therapeutics Holdings Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
20
12
15
20
9
12
205
157
138
67
Gross Profit
20
12
-1
20
-46
12
205
157
138
64
Operating Income
-25
-10
-21
-25
-71
-202
12
-78
-95
-74
EBITDA
0
-10
-20
-24
-70
-201
13
-24
-77
-71
Interest Expense
0
0
0
0
0
2
3
0
-
0
Depreciation
-
0
0
0
0
1
1
2
3
3
Income Before Tax
-24
-10
-21
-25
-72
-203
10
-27
-80
-65
Income Tax Expense
0
0
0
0
0
3
1
1
0
-75
Net Income
-24
-10
-21
-25
-72
-203
9
-29
-80
-65
Net Profit Margin
-120.71%
-83.87%
-138.29%
-125.02%
-756.35%
-1647.98%
4.54%
-18.84%
-58.49%
-97.86%

Arcturus Therapeutics Holdings Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-11
-26
-17
-6
-30
-14
-9
-13
-29
Operating Cash Flow
0
-5
-30
-23
0
-35
-5
-17
-16
Investing Cash Flow
0
0
0
0
0
0
0
0
0
Financing Cash Flow
-18
2
2
0
0
15
-14
1
11
Change in Cash
-20
-3
-28
-23
0
-20
-20
-16
-4

Arcturus Therapeutics Holdings Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-10
-21
-25
-72
-203
9
-29
-80
-65
Operating Cash Flow
0
-20
-6
-42
-135
31
-18
-59
-74
Investing Cash Flow
10
22
0
-1
-3
-7
-2
0
0
Financing Cash Flow
6
10
41
436
48
-2
-24
5
13
Change in Cash
16
11
34
391
-90
21
-45
-54
-61

Global Institutional Holdings in Arcturus Therapeutics Holdings Inc

Funds
Holdings
ARK Investment Management LLC
9.19%
Geode Capital Management, LLC
2.17%
The Goldman Sachs Group Inc
1.38%
Balyasny Asset Management LLC
3.18%
BlackRock Inc
9.02%
See all

Arcturus Therapeutics Holdings Inc News & Key Events

  • img

    Today's Timeline - 22 October

    Wed, 05:25 PM

    -

    Arcturus Therapeutics announces interim Phase 2 results for ARCT-032, showing it was generally safe and well tolerated.

    Wed, 06:57 PM

    -

    ARCT stock declines after interim Phase 2 trial results show no meaningful improvement in FEV values for ARCT-032.

    Thu, 00:35 AM

    -

    ARCT stock drops 56.30% after mixed Phase 2 trial results for ARCT-032, indicating no significant lung function improvement.

Insights on Arcturus Therapeutics Holdings Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 62.6% return, outperforming this stock by 129.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 18.2% return, outperforming this stock by 59.8%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, -9.18M → -29.07M (in $), with an average decrease of 81.4% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 4 quarters, 29.38M → 3.08M (in $), with an average decrease of 42.9% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 6 months, ARCT stock has moved down by -63.3%

About Arcturus Therapeutics Holdings Inc

founded in 2013 and based in san diego, calif., arcturus therapeutics is poised to become an industry leader in the application of rnai technologies for the treatment of disease and improved quality of life. the company’s aim is to develop breakthrough technology and novel therapeutics for rare diseases for which there is no adequate treatment. backed by a management team with extensive experience in the discovery and development of therapeutic modalities, arcturus is on the forefront of research and development of nanoparticle sirna drug delivery systems.
OrganisationArcturus Therapeutics Holdings Inc
Headquarters10285 Science Center Drive, San Diego, CA, United States, 92121
IndustryHealth Technology
CEOMr. Joseph E. Payne M.Sc.
E-voting on sharesClick here to vote

Key Management of Arcturus Therapeutics Holdings Inc

Name

Title

Mr. Joseph E. Payne M.Sc.

Founder, President, CEO & Director

Dr. Padmanabh Chivukula Ph.D.

Founder, Chief Scientific Officer, COO & Secretary

Mr. Lance Kurata

Chief Legal Officer

Ms. Neda Safarzadeh

Vice President and Head of IR/PR & Marketing

Dr. Igor Smolenov M.D., Ph.D.

Chief Development Officer

Dr. Ye Zhang

Chief Regulatory Officer

Mr. Joseph Roberts

Principal Financial & Accounting Officer and Controller

Ms. Natasha O. Bowman

Chief Human Resources Officer

Mr. Kevin T. Skol

Chief Business Officer

Dr. Alan H. Cohen FAAAAI, FAAP, FACAAI, FCCP, M.D.

Chief Medical Officer

FAQs

What is Arcturus Therapeutics Holdings Inc share price today?

Arcturus Therapeutics Holdings Inc share price today is $6.91 as on . Arcturus Therapeutics Holdings Inc share today touched a day high of $7.16 and a low of $6.92.

What is the 52 week high and 52 week low for Arcturus Therapeutics Holdings Inc share?

Arcturus Therapeutics Holdings Inc share touched a 52 week high of $24.17 on and a 52 week low of $5.85 on . Arcturus Therapeutics Holdings Inc stock price today i.e. is trending at $6.91,which is 71.41% down from its 52 week high and 18.12% up from its 52 week low.

What is Arcturus Therapeutics Holdings Inc's market capitalisation today?

Arcturus Therapeutics Holdings Inc market capitalisation is $0.00T as on .

How to invest in Arcturus Therapeutics Holdings Inc Stock (ARCT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Arcturus Therapeutics Holdings Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Arcturus Therapeutics Holdings Inc Shares that will get you 0.2171 shares as per Arcturus Therapeutics Holdings Inc share price of $6.91 per share as on March 30, 2026 at 7:38 pm IST.

What is the minimum amount required to buy Arcturus Therapeutics Holdings Inc Stock (ARCT) from India?

Indian investors can start investing in Arcturus Therapeutics Holdings Inc (ARCT) shares with as little as ₹94.702 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹947.02 in Arcturus Therapeutics Holdings Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Arcturus Therapeutics Holdings Inc share’s latest price of $6.91 as on March 30, 2026 at 7:38 pm IST, you will get 1.4472 shares of Arcturus Therapeutics Holdings Inc. Learn more about fractional shares .

What are the returns that Arcturus Therapeutics Holdings Inc has given to Indian investors in the last 5 years?

Arcturus Therapeutics Holdings Inc stock has given -82.55% share price returns and 29.05% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?